Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg

NCT06348303 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Metaxalone m640 mg oral tablet
DRUG: Metaxalone 800 mg oral tablet

Sponsor

Primus Pharmaceuticals

Collaborators

[object Object]